Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, has announced the appointment of Harold A. Deas, Jr as chief executive officer.
Harold, who will retain his role as chief operating officer, has been instrumental in helping Avion build a successful portfolio of women’s health and dermatology products. He will be driving corporate expansion while identifying strategic opportunities within the markets core to the company’s business.
Daily commercial operations and management will continue to be led by Michael E Sullivan.
‘Avion has a bright future, and I am pleased to be part of the continued success,’ commented Harold.
‘We have identified a multitude of exciting opportunities to drive growth and are working furiously to help materialize these opportunities for execution as part of our daily product sales efforts.’
